HSBC Holdings
TARS icon

HSBC Holdings’s Tarsus Pharmaceuticals TARS Stock Holding History

HSBC Holdings’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43M Buy
38,090
+28,447
+295% +$1.82M ﹤0.01% 1500
2026
Q1 		$686K Buy
+9,643
New +$674K ﹤0.01% 2059
2025
Q4 		– Sell
-3,521
Closed -$210K – 3152
2025
Q3 		$210K Sell
3,521
-1,789
-34% -$88.1K ﹤0.01% 2477
2025
Q2 		$219K Buy
5,310
+222
+4% +$9.99K ﹤0.01% 2634
2025
Q1 		$255K Buy
5,088
+154
+3% +$7.61K ﹤0.01% 2480
2024
Q4 		$273K Sell
4,934
-1,525
-24% -$69.3K ﹤0.01% 2550
2024
Q3 		$214K Sell
6,459
-2,608
-29% -$73.3K ﹤0.01% 2564
2024
Q2 		$241K Buy
+9,067
New +$305K ﹤0.01% 2443
2023
Q4 		– Sell
-12,903
Closed -$217K – 2910
2023
Q3 		$217K Sell
12,903
-2,860
-18% -$50.6K ﹤0.01% 2378
2023
Q2 		$285K Buy
15,763
+4,141
+36% +$65.8K ﹤0.01% 2174
2023
Q1 		$149K Buy
+11,622
New +$170K ﹤0.01% 2445

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HSBC Holdings's TARS Position: Q2 2026 in Review

HSBC Holdings increased its Tarsus Pharmaceuticals (TARS) stake by 295% in Q2 2026, buying an estimated $1.82M and bringing the position to 38,090 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1500.

HSBC Holdings first reported a position in TARS in Q1 2023 and has held it in 11 quarters since. 256 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • HSBC Holdings held 38,090 shares of Tarsus Pharmaceuticals worth $2.43M as of Q2 2026.
  • HSBC Holdings bought 28,447 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $1.82M.
  • Tarsus Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1500 holding.
  • HSBC Holdings first reported a position in Tarsus Pharmaceuticals in Q1 2023 and has held it in 11 quarters since.
  • 256 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.